Keith A. Goldan - 14 Jun 2024 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
14 Jun 2024
Net transactions value
+$25,037
Form type
4
Filing time
17 Jun 2024, 09:26:27 UTC
Previous filing
09 Feb 2024
Next filing
07 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Purchase $25,037 +1,250 +2.4% $20.03 52,623 14 Jun 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.